Preserving Hope, Extending Life.

OrganVive is a pioneering medical technology company dedicated to transforming organ transplantation through advanced ex vivo organ preservation platforms . By extending organ viability and enhancing the quality of marginal organs, OrganVive significantly increases the availability of transplantable organs, thereby saving more lives and improving patient outcomes.

Many patients lose their lives while waiting for a life-saving donor organ to become available.

Lung

> 12 million new cases of chronic lung disease reported per year worldwide

< 8000 lung transplant cases performed per year worldwide

> 80% of donated lungs are discarded

Heart

> 60 million new cases of chronic heart disease reported per year worldwide

< 10,000 heart transplant cases performed per year worldwide

>72% of donated hearts are discarded

Liver

> 9 million new cases of chronic liver diseases reported per year worldwide

< 22,000 liver transplant cases performed per year worldwide

> 34% of donated livers are discarded

Transforming the future of organ transplantation through advanced preservation, assessment and recovery technology

  • Recovery of Marginal Organs

  • Global Retrieval Range

Our current focus is on developing the next generation lung preservation platform —OrganVive-Lung—which is engineered to create an optimal bioenvironment for donor lung recovery.